BeStock  
Stocks › ADRX

Adarx Pharmaceuticals ADRX

US equityMarket cap rank #2804
$19.05 +$0.80 (+4.38%)
Pre-market · Oct 6, 7:10 am ET · After hours $19.05 0.00%
Open$18.25
Prev close$18.25
Day range$17.30 – $19.40
Volume914.0K
Market cap$1.95B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership49.4%+49.36 pts vs. prior quarter
Institutions holding5+5 vs. prior quarter
Insider trades (recent)10 buys / 0 sellsNet buying
Short-sale volume share22.7%5-day average of daily volume

Short-sale volume as % of daily volume

5%15%24%34%Sep '26Sep '26Oct '26

Large-order net flow, last 7 sessions

Net of large-order buying minus selling, in USD. Over this window: −$539.1K (2 inflow days, 5 outflow days).

The five largest holders on file together own 52.0% of shares outstanding.

Largest holders

  • OrbiMed Advisors LLC22.13%
  • Eli Lilly Investment Consulting (Shanghai) Co., Ltd.10.58%
  • SR One Capital Management, LP8.87%
  • Zhen Li5.23%
  • Li Zhen5.23%
  • Bcls Fund III Investments, Lp4.58%
  • TCG Crossover Management, LLC3.20%
  • Rui Zhu2.24%

By investor type

  • VC/PE Fund44.78%
  • Individual/Insider12.70%
  • Private Company4.58%

No ownership data on file for this stock.

Discussion

No comments yet — be the first to weigh in on ADRX.

Leave a comment

Scroll to Top